- Home
- TARA vs SKLZ Comparison
TARA vs SKLZ Comparison
Compare TARA & SKLZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARA
- SKLZ
- Stock Information
- Founded
- TARA N/A
- SKLZ 2012
- Country
- TARA United States
- SKLZ United States
- Employees
- TARA N/A
- SKLZ N/A
- Industry
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- SKLZ EDP Services
- Sector
- TARA Health Care
- SKLZ Technology
- Exchange
- TARA Nasdaq
- SKLZ Nasdaq
- Market Cap
- TARA 118.1M
- SKLZ 106.4M
- IPO Year
- TARA N/A
- SKLZ N/A
- Fundamental
- Price
- TARA $3.03
- SKLZ $8.90
- Analyst Decision
- TARA Strong Buy
- SKLZ Buy
- Analyst Count
- TARA 7
- SKLZ 1
- Target Price
- TARA $20.67
- SKLZ $14.00
- AVG Volume (30 Days)
- TARA 214.2K
- SKLZ 170.1K
- Earning Date
- TARA 08-11-2025
- SKLZ 08-07-2025
- Dividend Yield
- TARA N/A
- SKLZ N/A
- EPS Growth
- TARA N/A
- SKLZ N/A
- EPS
- TARA N/A
- SKLZ N/A
- Revenue
- TARA N/A
- SKLZ $93,320,000.00
- Revenue This Year
- TARA N/A
- SKLZ $0.20
- Revenue Next Year
- TARA N/A
- SKLZ $14.10
- P/E Ratio
- TARA N/A
- SKLZ N/A
- Revenue Growth
- TARA N/A
- SKLZ N/A
- 52 Week Low
- TARA $1.60
- SKLZ $3.54
- 52 Week High
- TARA $10.48
- SKLZ $9.11
- Technical
- Relative Strength Index (RSI)
- TARA 44.29
- SKLZ 63.81
- Support Level
- TARA $3.06
- SKLZ $6.60
- Resistance Level
- TARA $3.33
- SKLZ $8.72
- Average True Range (ATR)
- TARA 0.17
- SKLZ 0.55
- MACD
- TARA -0.01
- SKLZ 0.16
- Stochastic Oscillator
- TARA 4.65
- SKLZ 91.70
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About SKLZ Skillz Inc.
Skillz Inc is a mobile game development company. It is engaged in re-inventing competitive mobile gaming and thereby expanding the mobile gaming market. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The company's reportable business segments are; the Skillz segment and the Aarki segment. The majority of its revenue is generated from the Skillz segment which is an eSports gaming platform, enabling game developers to monetize their content through multi-player competition. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.